연구동향 분석

Helper virus-free gutless adenovirus (HF-GLAd): a new platform for gene therapy

Dai-Wu Seol Jida Liu 2020년

논문상세정보
인용/피인용
' Helper virus-free gutless adenovirus (HF-GLAd): a new platform for gene therapy' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • GLAd
  • Gene therapy
  • Gutlessadenovirus
  • HF-GLAd
  • Helper plasmid
  • Helper virus
  • adenovirus
  • geneticdisease
  • rca
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
128 0

0.0%

' Helper virus-free gutless adenovirus (HF-GLAd): a new platform for gene therapy' 의 참고문헌

  • What is immune privilege (not)?
    Galea I [2007]
  • Visual prognosis in USH2A-associated retinitis pigmentosa is worse for patients with usher syndrome type iia than for those with nonsyndromic retinitis pigmentosa
  • Variables affecting in vivo performance of high-capacity adenovirus vectors
    Schiedner G [2002]
  • Understanding the process of fibrosis in Duchenne muscular dystrophy
    Kharraz Y [2014]
  • Transient immunosuppression with deoxyspergualin improves longevity of transgene expression and ability to readminister adenoviral vector to the mouse lung
    Kaplan JM [1997]
  • Transient depletion of specific immune cell populations to improve adenovirus-mediated transgene expression in the liver
    Alzuguren P [2015]
  • Toxicological comparison of E2a-deleted and first-generation adenoviral vectors expressing alpha1-antitrypsin after systemic delivery
    O’Neal WK [1998]
  • Toxicity of a first-generation adenoviral vector in rhesus macaques
    Lozier JN [2002]
  • The status of RPE65 gene therapy trials : safety and efficacy
    Pierce EA [2015]
  • The privileged immunity of immune privileged organs : the case of the eye
    Benhar I [2012]
  • The ATP-binding cassette transporter ABCA4 : structural and functional properties and role in retinal disease
  • T lymphocyte-directed gene therapy for ADA-SCID : initial trial results after 4 years
    Blaese RM [1995]
  • Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination
    Hammerich L [2019]
  • Systemic AAV micro-dystrophin gene therapy for duchenne muscular dystrophy
    Duan D [2018]
  • Sustained transgene expression using MAR elements
    Harraghy N [2008]
  • Sustained improvement of muscle function one year after full-length dystrophin gene transfer into mdx mice by a gutted helper-dependent adenoviral vector
    Dudley RW [2004]
  • Safety and immunogenicity of the Merck adenovirus serotype 5(MRKAd5)and MRKAd6 human immunodeficiency virus type 1trigene vaccines alone and in combination in healthy adults
    Harro C [2009]
  • Regulation of adenovirus E2 transcription unit; in the molecular repertoire of adenoviruses III: biology and pathogenesis
  • Recovery of new agent from patients with acute respiratory illness
    Hilleman MR [1954]
  • Recombinant adenovirus is an efficient and non-perturbing genetic vector for human dendritic cells
    Zhong L [1999]
  • Purification of the recombinant adenovirus by cesium chloride gradient centrifugation
    Su Q [2019]
  • Pre-existing immunity against Ad vectors: humoral, cellular, and innate response, what’s important?
  • Packaging capacity and stability of human adenovirus type 5 vectors
    Bett AJ [1993]
  • Overexpression of Ad5 precursor terminal protein accelerates recombinant adenovirus packaging and amplification in HEK-293 packaging cells
    Wu N [2014]
  • Optimization of the helper-dependent adenovirus system for production and potency in vivo
    Sandig V [2000]
  • Oncolytic adenoviruses in cancer treatment
    Alemany R [2014]
  • Oncolytic adenovirus programmed by synthetic gene circuit for cancer immunotherapy
    Huang H [2019]
  • Oncolytic adenovirus and tumor-targeting immune modulatory therapy improve autologous cancer vaccination
    Jiang H [2017]
  • Onasemnogene abeparvovec for spinal muscular atrophy : the costlier drug ever
    Mahajan R [2019]
  • Nonspecific inflammation inhibits adenovirus-mediated pulmonary gene transfer and expression independent of specific acquired immune responses
    Otake K [1998]
  • No more helper adenovirus: production of gutless adenovirus (GLAd) free of adenovirus and replication-competent adenovirus (RCA) contaminants
    Dongwoo Lee [2019]
  • New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses
    Fallaux FJ [1998]
  • Neutralizing antibody blocks adenovirus infection by arresting microtubule-dependent cytoplasmic transport
    Smith JG [2008]
  • Mutations in the CEP290(NPHP6)gene are a frequent cause of Leber congenital amaurosis
  • Molecular characterization of an adenoviral vector resulting from both homologous and nonhomologous recombination
    Smith JG [1999]
  • Luxturna : FDA documents reveal the value of a costly gene therapy
    Darrow JJ [2019]
  • Low-dose gene therapy reduces the frequency of enzyme replacement therapy in a mouse model of lysosomal storage disease
    Alliegro M [2016]
  • Large-scale production of high-quality helperdependent adenoviral vectors using adherent cells in cell factories
    Suzuki M [2010]
  • Isolation of a cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture
    Rowe WP [1953]
  • Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration
    Worgall S [1997]
  • Improved system for helperdependent adenoviral vector production
    Palmer D [2003]
  • Immune response to recombinant adenovirus in humans : capsid components from viral input are targets for vector-specific cytotoxic T lymphocytes
  • Huntington disease
    Bates GP [2015]
  • Hemophilia B gene therapy with a high-specific-activity factor IX variant
    George LA [2017]
  • Helperdependent adenovirus vectors elicit intact innate but attenuated adaptive host immune responses in vivo
    Muruve DA [2004]
  • HIV-1vaccine-induced immunity in the test-of-concept Step Study : a case-cohort analysis
    McElrath MJ [2008]
  • Gutless adenoviral vectors-promising tools for gene therapy
    Jozkowicz A [2002]
  • Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients
    Bordignon C [1995]
  • Gene therapy in Alzheimer’s disease-potential for disease modification
    Nilsson P [2010]
  • Gene therapy for Parkinson’s disease, an update
    Axelsen TM [2018]
  • Gene therapy death prompts review of adenovirus vector
    Marshall E [1999]
  • Functions and mechanisms of action of the adenovirus E3 proteins
  • FDA Perspectives on the use of the adenovirus reference material
    Simek S [2002]
  • Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency
    Kohn DB [1995]
  • Endgame : glybera finally recommended for approval as the first gene therapy drug in the European union
  • Emergence of early region 1-containing replication-competent adenovirus in stocks of replication-defective adenovirus recombinants(delta E1 + delta E3)during multiple passages in 293 cells
  • Efficacy and biodistribution analysis of intracerebroventricular administration of an optimized scAAV9-SMN1 vector in a mouse model of spinal muscular atrophy
  • Effects of stuffer DNA on transgene expression from helper-dependent adenovirus vectors
    Parks RJ [1999]
  • Effect of preexisting immunity on an adenovirus vaccine vector : in vitro neutralization assays fail to predict inhibition by antiviral antibody in vivo
  • Effect of neutralizing sera on factor x-mediated adenovirus serotype 5 gene transfer
    Parker AL [2009]
  • Ebola virus vaccine : benefit and risks of adenovirus-based vectors
  • EYS mutations causing autosomal recessive retinitis pigmentosa : changes of retinal structure and function with disease progression
    McGuigan DB [2017]
  • E-cadherin intron 2 contains cis-regulatory elements essential for gene expression
    Stemmler MP [2005]
  • Dystrophin expression in muscle following gene transfer with a fully deleted (“gutted”) adenovirus is markedly improved by trans-acting adenoviral gene products
    Gilbert R [2001]
  • Distinct roles of the adenovirus E4 ORF3 protein in viral DNA replication and inhibition of genome concatenation
    Evans JD [2003]
  • Development of a FLP/frt system for generating helper-dependent adenoviral vectors
    Ng P [2001]
  • Current issues and future directions of oncolytic adenoviruses
    Yamamoto M [2010]
  • Complex inheritance of ABCA4 disease : four mutations in a family with multiple macular phenotypes
    Lee W [2016]
  • Complementation of helper-dependent adenoviral vectors : size effects and titer fluctuations
    Alemany R [1997]
  • Common control of the heat shock gene and early adenovirus genes : evidence for a cellular E1A-like activity
  • Coexpression of tyrosine hydroxylase, GTP cyclohydrolase I, aromatic amino acid decarboxylase, and vesicular monoamine transporter 2 from a helper virus-free herpes simplex virus type 1 vector supports high-level, long-term biochemical and behavioral correction of a rat model of Parkinson’s disease
    Sun M [2004]
  • Cloning and sequencing of the cellular-viral junctions from the human adenovirus type 5 transformed 293 cell line
    Louis N [1997]
  • Class I-restricted T-cell responses to a polymorphic peptide in a gene therapy clinical trial for alpha-1-antitrypsin deficiency
    Calcedo R [2017]
  • Cis-acting induction of adenovirus transcription
    Gaynor RB [1983]
  • Chimpanzee adenovirus-and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults
    Green CA [2015]
  • Characteristics of a human cell line transformed by DNA from human adenovirus type 5
    Graham FL [1977]
  • Cellular immune response to adenoviral vector infected cells does not require de novo viral gene expression : implications for gene therapy
    Kafri T [1998]
  • Cellular and humoral immune responses to adenoviral vectors containing factor IX gene : tolerization of factor IX and vector antigens allows for long-term expression
    Dai Y [1995]
  • An adenovirus-based vaccine with a double-stranded RNA adjuvant protects mice and ferrets against H5N1 avian influenza in oral delivery models
    Scallan CD [2013]
  • An HSV amplicon-based helper system for helper-dependent adenoviral vectors
    Kubo S [2003]
  • Adenovirusmediated transfer of the CFTR gene to lung of nonhuman primates : biological efficacy study
  • Adenovirusmediated gene delivery : potential applications for gene and cell-based therapies in the new era of personalized medicine
    Lee CS [2017]
  • Adenovirus infection triggers a rapid, MyD88-regulated transcriptome response critical to acute-phase and adaptive immune responses in vivo
    Hartman ZC [2007]
  • Adenovirus efficiently transduces plasmacytoid dendritic cells resulting in TLR9-dependent maturation and IFN-alpha production
  • Adenovirus complexed with polyethylene glycol and cationic lipid is shielded from neutralizing antibodies in vitro
    Chillon M [1998]
  • Adenovirus : the first effective in vivo gene delivery vector
    Crystal RG [2014]
  • Adeno-associated virus(AAV)as a vector for gene therapy
    Naso MF [2017]
  • Adeno-associated virus vector as a platform for gene therapy delivery
    Wang D [2019]
  • Acute toxicity after high-dose systemic injection of helper-dependent adenoviral vectors into nonhuman primates
  • Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors
    Schnell MA [2001]
  • A single short stretch of homology between adenoviral vector and packaging cell line can give rise to cytopathic effect-inducing, helper-dependent E1-positive particles
    Murakami P [2002]
  • A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier
    Xiang ZQ [1996]
  • A rapid protocol for construction and production of high-capacity adenoviral vectors
    Jager L [2009]
  • A novel system for the production of fully deleted adenovirus vectors that does not require helper adenovirus
    Cheshenko N [2001]
  • A human type 5 adenovirus-based tuberculosis vaccine induces robust T cell responses in humans despite preexisting anti-adenovirus immunity
    Smaill F [2013]
  • A helper-dependent system for adenovirus vector production helps define a lower limit for efficient DNA packaging
    Parks RJ [1997]
  • A helper-dependent adenovirus vector system : removal of helper virus by Cre-mediated excision of the viral packaging signal
    Parks RJ [1996]
  • 160. Gene therapy for stargardt disease using helper-dependent adenoviral vectors
    Guse K [2012]
  • "Stealth"adenoviruses blunt cell-mediated and humoral immune responses against the virus and allow for significant gene expression upon readministration in the lung
    Croyle MA [2001]